UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): October 20, 2025
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)
|
Delaware
|
|
0-16469
|
|
13-3275609
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
Commission
File Number
|
|
(I.R.S. Employer
Identification No.)
|
551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)
212.983.2640
(Registrant’s Telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
|
|
|
|
|
|
|
Common Stock, $.001 par value per share
|
|
IPAR
|
|
The Nasdaq Stock Market
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Conditions
Certain
portions of our press release dated October 20, 2025, a copy of which is
annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and
are filed pursuant to this Item 2.02. They are as follows:
- The 1st, 2nd (consisting of a table), and 3rd, 5th, 7th, and 10th
full paragraphs relating to net sales for the third quarter and nine (9) months
ended September 30, 2025
- Portions of the 4th, 6th 8th and
9th paragraphs relating to net sales for the third quarter and nine (9) months
ended September 30, 2025
Item 7.01 Regulation FD Disclosure
Certain
portions of our press release dated October 20, 2025, a copy of which is
annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and
are filed pursuant to this Item 7.01. They are as follows:
- Portion of the 4th paragraph relating to
potential future Lacoste sales levels
- Portion of the 6th paragraph
relating to the new
Montblanc
fragrance and its potential for the remainder of
2025 and 2026
-
Portion of the 8th paragraph relating to
GUESS’ potential sales in the fourth quarter of 2025
- Portion of the 9th paragraph relating to
Donna Karan/DKNY potential holiday sales in the fourth quarter of 2025
- Portion of the 11th paragraph relating to the
Company’s future pricing increase, planned innovation pipelines, macroeconomic
headwinds and potential sales for the 2025 fourth quarter and 2026
- The 12th paragraph relating to the Company’s plans to release
its earnings for the three and nine months ended September 30, 2025 on Wednesday,
November 5, 2025
- Portion of the 12th paragraph and the 13th
through 15th full paragraphs relating to the conference call
scheduled for November 6, 2025
- The 18th paragraph relating to forward-looking
information
- The balance of such press release not otherwise
incorporated by reference in 2.02
Item 9.01 Financial Statements and Exhibits.
| 99.1 |
Our press release dated October 20, 2025 |
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.
Dated: October 20, 2025
|
|
Interparfums, Inc.
|
|
|
|
|
|
By:
|
/s/ Michel Atwood
|
|
|
|
Michel Atwood,
|
|
|
|
Chief Financial Officer
|
